Novaliq GmbH

We are a Germany based specialty pharmaceutical with a highly innovative and proprietary drug delivery technology platform called EyeSol®, focusing on ophthalmology. Our mission is to transform poorly soluble drugs into effective ocular therapeutics for both front and back of the eye. Our first OTC product is marketed within Europe since Q4 2015. Our most advanced prescription candidate is currently being tested in a large phase II US trial in moderate to severe dry Eye disease. Within our development we further focus on drug candidates based on our disruptive technology platform for the application in Glaucoma, Retinal diseases and beyond.
 

Details


Adresse:
Novaliq GmbH

Im Neuenheimer Feld 515
69120 Heidelberg
Deutschland
Arbeitsgebiet:
Klinische Forschung
Forschung & Entwicklung
Management & Business Development
Qualitätsmanagement
Regulatory Affairs
Sonstige Tätigkeitsfelder
Wissenschaftliche/r Mitarbeiter/in
Expansion:
international
Webseite:
Mitarbeiteranzahl:
51-500
Gründungsjahr:
2004